Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Label-free detection and profiling of individual solution-phase molecules.
Needham LM, Saavedra C, Rasch JK, Sole-Barber D, Schweitzer BS, Fairhall AJ, Vollbrecht CH, Wan S, Podorova Y, Bergsten AJ, Mehlenbacher B, Zhang Z, Tenbrake L, Saimi J, Kneely LC, Kirkwood JS, Pfeifer H, Chapman ER, Goldsmith RH. Needham LM, et al. Among authors: schweitzer bs. Nature. 2024 May 8. doi: 10.1038/s41586-024-07370-8. Online ahead of print. Nature. 2024. PMID: 38720082
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.
Antoniotti C, Boccaccino A, Seitz R, Giordano M, Catteau A, Rossini D, Pietrantonio F, Salvatore L, McGregor K, Bergamo F, Conca V, Leonetti S, Morano F, Papiani G, Tamburini E, Bensi M, Murgioni S, Ross DT, Passardi A, Boquet I, Nielsen TJ, Galon J, Varga MG, Schweitzer BL, Cremolini C. Antoniotti C, et al. Among authors: schweitzer bl. Clin Cancer Res. 2023 Jun 13;29(12):2291-2298. doi: 10.1158/1078-0432.CCR-22-3878. Clin Cancer Res. 2023. PMID: 37022350 Clinical Trial.
Label-free observation of individual solution phase molecules.
Needham LM, Saavedra C, Rasch JK, Sole-Barber D, Schweitzer BS, Fairhall AJ, Vollbrecht CH, Mehlenbacher B, Zhang Z, Tenbrake L, Pfeifer H, Chapman ER, Goldsmith RH. Needham LM, et al. Among authors: schweitzer bs. bioRxiv [Preprint]. 2023 Mar 25:2023.03.24.534170. doi: 10.1101/2023.03.24.534170. bioRxiv. 2023. PMID: 36993572 Free PMC article. Preprint.
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.
Nielsen TJ, Varga MG, Cronister CT, Ring BZ, Seitz RS, Ross DT, Schweitzer BL, McGregor K. Nielsen TJ, et al. Among authors: schweitzer bl. Cancer Immunol Immunother. 2023 Jul;72(7):2075-2086. doi: 10.1007/s00262-023-03401-x. Epub 2023 Feb 19. Cancer Immunol Immunother. 2023. PMID: 36806983 Free PMC article.
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
Saltman DL, Varga MG, Nielsen TJ, Croteau NS, Lockyer HM, Jain AL, Vidal GA, Hout DR, Schweitzer BL, Seitz RS, Ross DT, Gandara DR. Saltman DL, et al. Among authors: schweitzer bl. Clin Lung Cancer. 2023 Mar;24(2):137-144. doi: 10.1016/j.cllc.2022.11.009. Epub 2022 Dec 5. Clin Lung Cancer. 2023. PMID: 36564297 Free article.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
221 results